UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035985
Receipt number R000040988
Scientific Title Effect of kinesthetic illusion induced by visual stimulation in patients with stroke
Date of disclosure of the study information 2019/02/25
Last modified on 2020/08/25 09:07:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of kinesthetic illusion induced by visual stimulation in patients with stroke

Acronym

Effect of kinesthetic illusion induced by visual stimulation in patients with stroke

Scientific Title

Effect of kinesthetic illusion induced by visual stimulation in patients with stroke

Scientific Title:Acronym

Effect of kinesthetic illusion induced by visual stimulation in patients with stroke

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of therapy with kinesthetic illusion induced by visual stimulation five days per week for two weeks on the paretic upper extremity after stroke.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluation of upper extremity function (Fugl-Meyer Assessment, etc)

Key secondary outcomes

Magnetoencephalography


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

20 minutes for kinesthetic illusion induced by visual stimulation five days per week for two weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) ischemic or hemorrhagic stroke
2) more than 90 days after stroke onset
3) motor paresis on upper extremity
4) ability to flex fingers partially, inability to extend fingers
5) not severe contracture on finger joints

Key exclusion criteria

1) severe medical comorbidities unable to perform the therapy
2) severe cognitive or psychiatric disorder
3) pacemaker or implantable cardioverter defibrillators
4) history of epilepsy within 30 days
5) history of specific neurorehabilitation such as rTMS, tDCS, functional electrical stimilation, and repetitive facilitative exercise, and constraint induced movement therapy within 30 days
6) history of botulinum toxin injection or nerve block within 30 days

Target sample size

11


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryosuke Takahashi

Organization

Hokuto Hospital

Division name

Department of Medical Technology

Zip code


Address

7-5 Kisen, Inada-cho, Obihiro-shi, Hokkaido

TEL

0155-48-8000

Email

hokutopt.takahashi@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Ryosuke Takahashi

Organization

Hokuto Hospital

Division name

Department of Medical Technology

Zip code


Address

7-5 Kisen, Inada-cho, Obihiro-shi, Hokkaido

TEL

0155-48-8000

Homepage URL


Email

hokutopt.takahashi@gmail.com


Sponsor or person

Institute

Hokuto Hospital

Institute

Department

Personal name



Funding Source

Organization

Hokuto Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 01 Day

Date of IRB

2018 Year 02 Month 28 Day

Anticipated trial start date

2018 Year 06 Month 01 Day

Last follow-up date

2020 Year 01 Month 30 Day

Date of closure to data entry

2020 Year 02 Month 01 Day

Date trial data considered complete

2020 Year 02 Month 01 Day

Date analysis concluded

2020 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 02 Month 23 Day

Last modified on

2020 Year 08 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040988


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name